Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

RL Jones; MJ Ratain; PJ O'Dwyer; LL Siu; J Jassem; J Medioni; Maja de Jonge; C Rudin; M Sawyer; D Khayat; A Awada; J de Vos-Geelen; TRJ Evans; J Obel; B Brockstein; J DeGreve; JF Baurain; R Maki; D D'Adamo; M Dickson; S Undevia; D Geary; L Janisch; PL Bedard; ARA Razak; R Kristeleit; J Vitfell-Rasmussen; I Walters; SB Kaye; G Schwartz

doi:10.1016/j.ejca.2019.07.024

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

RL Jones, MJ Ratain, PJ O'Dwyer, LL Siu, J Jassem, J Medioni, Maja de Jonge, C Rudin, M Sawyer, D Khayat, A Awada, J de Vos-Geelen, TRJ Evans, J Obel, B Brockstein, J DeGreve, JF Baurain, R Maki, D D'Adamo, M DicksonS Undevia, D Geary, L Janisch, PL Bedard, ARA Razak, R Kristeleit, J Vitfell-Rasmussen, I Walters, SB Kaye, G Schwartz

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

27 Citations (Scopus)

29 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	132-139
Number of pages	8
Journal	European Journal of Cancer
Volume	120
DOIs	https://doi.org/10.1016/j.ejca.2019.07.024
Publication status	Published - 2019

Research programs

EMC OR-01

Access to Document

10.1016/j.ejca.2019.07.024

Repub_119604_O-A.pdfFinal published version, 738 KB

http://hdl.handle.net/1765/119604

Cite this

Jones, RL., Ratain, MJ., O'Dwyer, PJ., Siu, LL., Jassem, J., Medioni, J., de Jonge, M., Rudin, C., Sawyer, M., Khayat, D., Awada, A., de Vos-Geelen, J., Evans, TRJ., Obel, J., Brockstein, B., DeGreve, J., Baurain, JF., Maki, R., D'Adamo, D., ... Schwartz, G. (2019). Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. European Journal of Cancer, 120, 132-139. https://doi.org/10.1016/j.ejca.2019.07.024

@article{798050b5bc7d42efaed9c6157496502d,

title = "Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours",

author = "RL Jones and MJ Ratain and PJ O'Dwyer and LL Siu and J Jassem and J Medioni and \{de Jonge\}, Maja and C Rudin and M Sawyer and D Khayat and A Awada and \{de Vos-Geelen\}, J and TRJ Evans and J Obel and B Brockstein and J DeGreve and JF Baurain and R Maki and D D'Adamo and M Dickson and S Undevia and D Geary and L Janisch and PL Bedard and ARA Razak and R Kristeleit and J Vitfell-Rasmussen and I Walters and SB Kaye and G Schwartz",

year = "2019",

doi = "10.1016/j.ejca.2019.07.024",

language = "Undefined/Unknown",

volume = "120",

pages = "132--139",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Jones, RL, Ratain, MJ, O'Dwyer, PJ, Siu, LL, Jassem, J, Medioni, J, de Jonge, M, Rudin, C, Sawyer, M, Khayat, D, Awada, A, de Vos-Geelen, J, Evans, TRJ, Obel, J, Brockstein, B, DeGreve, J, Baurain, JF, Maki, R, D'Adamo, D, Dickson, M, Undevia, S, Geary, D, Janisch, L, Bedard, PL, Razak, ARA, Kristeleit, R, Vitfell-Rasmussen, J, Walters, I, Kaye, SB & Schwartz, G 2019, 'Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours', European Journal of Cancer, vol. 120, pp. 132-139. https://doi.org/10.1016/j.ejca.2019.07.024

TY - JOUR

T1 - Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

AU - Jones, RL

AU - Ratain, MJ

AU - O'Dwyer, PJ

AU - Siu, LL

AU - Jassem, J

AU - Medioni, J

AU - de Jonge, Maja

AU - Rudin, C

AU - Sawyer, M

AU - Khayat, D

AU - Awada, A

AU - de Vos-Geelen, J

AU - Evans, TRJ

AU - Obel, J

AU - Brockstein, B

AU - DeGreve, J

AU - Baurain, JF

AU - Maki, R

AU - D'Adamo, D

AU - Dickson, M

AU - Undevia, S

AU - Geary, D

AU - Janisch, L

AU - Bedard, PL

AU - Razak, ARA

AU - Kristeleit, R

AU - Vitfell-Rasmussen, J

AU - Walters, I

AU - Kaye, SB

AU - Schwartz, G

PY - 2019

Y1 - 2019

U2 - 10.1016/j.ejca.2019.07.024

DO - 10.1016/j.ejca.2019.07.024

M3 - Article

C2 - 31522033

SN - 0959-8049

VL - 120

SP - 132

EP - 139

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -